Top 10 alternative sites to zemaira.com
PROLASTIN®-C Liquid for Alpha1-Antitrypsin Deficiency
Get information about alpha1-antitrypsin deficiency: disease overview, symptoms, treatment options, PROLASTIN-C Liquid therapy, support program, and more.
Iron Deficiency Anemia Treatment | FERAHEME® HCP
Learn about FERAHEME® (ferumoxytol injection), an effective IV iron treatment for eligible iron deficiency anemia (IDA) patients. See Boxed Warning.
Treatment For ITP & CLD Patients | DOPTELET® (avatrombopag) HCP
Learn more about DOPTELET® (avatrombopag) for your patients, indicated for adults with chronic Immune Thrombocytopenia (ITP) or Chronic Liver Disease (CLD)
MCL and CLL/SLL Treatment | CALQUENCE® (acalabrutinib) 100 mg capsules | For HCPs
CALQUENCE® (acalabrutinib) is a BTK inhibitor indicated for the treatment of adult patients with R/R Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
Some websites with similar theme to zemaira.com include:
HAEGARDA® Helps Prevent Hereditary Angioedema (HAE) Attacks
As a preventive therapy, HAEGARDA can effectively reduce the number of Hereditary Angioedema (HAE) attacks you experience.
The #1 prescribed von Willebrand Factor*
HUMATE-P is a VWF/FVIII replacement therapy for people with von Willebrand disease (VWD). HUMATE-P provides bleed control across all VWD types. Learn about VWD.
Factor IX Therapy for Hemophilia B | IDELVION coagulation factor IX (recombinant), albumin fusion protein
IDELVION is the only extended half-life Factor IX therapy that delivers zero bleeds, 14-day dosing and 20% FIX trough levels for hemophilia B.
PI and CIDP Treatment | HIZENTRA® Immune Globulin Subcutaneous (Human) 20% Liquid
Learn more about the benefits of Hizentra, a subcutaneous immunoglobulin therapy for PI and CIDP. Please see Important Safety Information.
Home | BERINERT C1 Esterase Inhibitor, Human
Learn about BERINERT C1-INH replacement therapy for on-demand treatment of HAE attacks.
Factor VIII Therapy for Hemophilia A | AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
Learn about AFSTYLA, a Factor VIII therapy that provides long-lasting bleed protection for people with hemophilia A. Also explore how to get a free trial.